| Jill M Prilliman, OD | |
|
135 S Andover Rd, Andover, KS 67002-8037 | |
| (316) 733-4322 | |
| (316) 733-5860 |
| Full Name | Jill M Prilliman |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 12 Years |
| Location | 135 S Andover Rd, Andover, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174879100 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1919 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steven A Kuhl Od Llc | 7113321498 | 38 |
News Archive
Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced that the company's Surefire Infusion System will be used in the development of the first clinically viable microcatheter-based, minimally invasive treatment for obesity as an alternative to bariatric surgery.
The efficacy of interferon (IFN) therapy depends on the hepatitis C virus (HCV) genotype, pretreatment viral load and early viral kinetics. Thus, IFN therapy must be individualized and optimized according to the virological and clinical status of each patient.
Cigarette smoking kills approximately 440,000 Americans each year, according to the Centers for Disease Control and Protection. It's the leading cause of preventable death worldwide. In order to overcome this addiction, many people resort to nicotine replacement therapies.
Funding and publication of gun violence research are disproportionately low compared to other leading causes of death in the United States, according to new research from the Icahn School of Medicine at Mount Sinai published online today in the Journal of the American Medical Association.
› Verified 7 days ago
| Provider Name | Grene Vision Group Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1285627562 PECOS PAC ID: 1254324023 Enrollment ID: O20040407000095 |
News Archive
Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced that the company's Surefire Infusion System will be used in the development of the first clinically viable microcatheter-based, minimally invasive treatment for obesity as an alternative to bariatric surgery.
The efficacy of interferon (IFN) therapy depends on the hepatitis C virus (HCV) genotype, pretreatment viral load and early viral kinetics. Thus, IFN therapy must be individualized and optimized according to the virological and clinical status of each patient.
Cigarette smoking kills approximately 440,000 Americans each year, according to the Centers for Disease Control and Protection. It's the leading cause of preventable death worldwide. In order to overcome this addiction, many people resort to nicotine replacement therapies.
Funding and publication of gun violence research are disproportionately low compared to other leading causes of death in the United States, according to new research from the Icahn School of Medicine at Mount Sinai published online today in the Journal of the American Medical Association.
› Verified 7 days ago
| Provider Name | Steven A Kuhl Od Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1205415387 PECOS PAC ID: 7113321498 Enrollment ID: O20210809002157 |
News Archive
Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced that the company's Surefire Infusion System will be used in the development of the first clinically viable microcatheter-based, minimally invasive treatment for obesity as an alternative to bariatric surgery.
The efficacy of interferon (IFN) therapy depends on the hepatitis C virus (HCV) genotype, pretreatment viral load and early viral kinetics. Thus, IFN therapy must be individualized and optimized according to the virological and clinical status of each patient.
Cigarette smoking kills approximately 440,000 Americans each year, according to the Centers for Disease Control and Protection. It's the leading cause of preventable death worldwide. In order to overcome this addiction, many people resort to nicotine replacement therapies.
Funding and publication of gun violence research are disproportionately low compared to other leading causes of death in the United States, according to new research from the Icahn School of Medicine at Mount Sinai published online today in the Journal of the American Medical Association.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jill M Prilliman, OD 1851 N Webb Rd, Wichita, KS 67206-3413 Ph: (316) 858-3831 | Jill M Prilliman, OD 135 S Andover Rd, Andover, KS 67002-8037 Ph: (316) 733-4322 |
News Archive
Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced that the company's Surefire Infusion System will be used in the development of the first clinically viable microcatheter-based, minimally invasive treatment for obesity as an alternative to bariatric surgery.
The efficacy of interferon (IFN) therapy depends on the hepatitis C virus (HCV) genotype, pretreatment viral load and early viral kinetics. Thus, IFN therapy must be individualized and optimized according to the virological and clinical status of each patient.
Cigarette smoking kills approximately 440,000 Americans each year, according to the Centers for Disease Control and Protection. It's the leading cause of preventable death worldwide. In order to overcome this addiction, many people resort to nicotine replacement therapies.
Funding and publication of gun violence research are disproportionately low compared to other leading causes of death in the United States, according to new research from the Icahn School of Medicine at Mount Sinai published online today in the Journal of the American Medical Association.
› Verified 7 days ago
Sparks Eye Care Llc Optometrist Medicare: Medicare Enrolled Practice Location: 307 W Hwy 54, Ste 100, Andover, KS 67002 Phone: 316-201-1837 | |
Ashley Ralston, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 308 E Central Ave Ste 100, Andover, KS 67002 Phone: 316-927-2200 Fax: 316-927-2343 | |
Giannetti & Ralston Eye Care Of Andover, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 308 E Central Ave Ste 100, Andover, KS 67002 Phone: 316-775-6341 Fax: 316-775-6680 | |
Steven A. Kuhl Od, Llc Optometrist Medicare: Medicare Enrolled Practice Location: Steven A. Kuhl Od, Llc, 135 S. Andover Rd, Andover, KS 67002 Phone: 316-733-4322 Fax: 316-733-5860 | |
Grene Vision Group Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 135 S Andover Rd, Andover, KS 67002 Phone: 316-733-4322 Fax: 316-733-5860 | |
Dr. Rebecca C. Sparks, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 307 W Hwy 54, Ste 100, Andover, KS 67002 Phone: 316-201-1837 |